BIOECLOSION
BioEclosion seeks to enhance user-friendly quantitative diagnostics to new molecular biomarkers for fast identification of emerging diseases that affect global health. The company started its activity with several patents, the most important being Celifast: a non-invasive approach for the detection of celiac disease. Addressing point of care attention of patients, the core technology has been successfully validated and the team is currently working on further development for commercialization.
BIOECLOSION
Social Links:
Industry:
Biotechnology Health Care Hospital
Founded:
2016-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.bioeclosion.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Organization Schema Google Maps
Similar Organizations
Aps Biocontrol
APS Biocontrol develops biocontrol solutions for the management of bacterial diseases and other microbial contaminants.
Current Employees Featured
Founder
Investors List
MassChallenge Switzerland
MassChallenge Switzerland investment in Non Equity Assistance - BioEclosion
IQS Tech Factory
IQS Tech Factory investment in Funding Round - BioEclosion
Official Site Inspections
http://www.bioeclosion.com
- Host name: com1029.raiolanetworks.es
- IP address: 178.211.133.59
- Location: Ukraine
- Latitude: 50.4522
- Longitude: 30.5287
- Timezone: Europe/Kiev
More informations about "BioEclosion"
BioEclosion – ENHANCING RAPID TESTS FOR WORLDWIDE …
Latest news Bioeclosion participates in S2 Xpeed acceleration program and ‘Fira de la Innovació’ at UAB Join us at the Health Revolution Congress on May 16th in Barcelona for an inspiring …See details»
About us - BioEclosion
Aug 6, 2019 BioEclosion is a young company resulting from the efforts of its founders and the Universitat Autònoma de Barcelona. Born in 2016, its main objective is the development and …See details»
BioEclosion - Crunchbase Company Profile & Funding
BioEclosion seeks to enhance user-friendly quantitative diagnostics to new molecular biomarkers for fast identification of emerging diseases that affect global health. The company started its …See details»
BioEclosion Company Profile 2024: Valuation, Funding & Investors ...
Information on valuation, funding, cap tables, investors, and executives for BioEclosion. Use the PitchBook Platform to explore the full profile.See details»
BioEclosion SL - LinkedIn
BioEclosion SL Hospitals and Health Care Cerdanyola del Valles, Barcelona 131 followers The Next generation of rapid diagnostic test for low-resource settings to solve the societal …See details»
BioEclosion - Craft
BioEclosion is a company developing diagnostic devices. It focuses on the isolation of targets from complex specimens using magnetic peptides, magnetic molecularly-imprinted polymeric …See details»
BioEclosion - Products, Competitors, Financials, Employees ...
BioEclosion's products are designed for applications in global disease detection, food safety, and environmental monitoring. It was founded in 2016 and is based in Barcelona, Spain.See details»
BioEclosion - Funding, Financials, Valuation & Investors
May 17, 2021 BioEclosion aims to contribute in the development of the next generation of rapid diagnostic test (RDTs) to solve societal challenges.See details»
Contact us - BioEclosion
BioEclosion SLEdifici EurekaAvinguda Can DomènechBellaterra, Barcelona 08193Spain [email protected] +34 670311524See details»
BioEclosion - Crunchbase
BioEclosion aims to contribute in the development of the next generation of rapid diagnostic test (RDTs) to solve societal challenges.See details»
Bioeclosion, a spin-off created by staff from the Department of ...
Feb 29, 2024 The company Bioeclosion, which produces new diagnostic devices based on next-generation biosensors and was created by research staff from the Department of Chemistry …See details»
BioEclosion - Tech Stack, Apps, Patents & Trademarks
BioEclosion aims to contribute in the development of the next generation of rapid diagnostic test (RDTs) to solve societal challenges.See details»
BioEclosion Presents Breakthrough Technology and Investment …
Dec 16, 2023 Last week, Dr. Jofre Ferrer-Dalmau, CEO, presented Bioeclosion at the UAB Investment forum, as closure event of Arquímedes acceleration program. Dr. Ferrer-Dalmau …See details»
bioeclosion - GitHub
People This organization has no public members. You must be a member to see who’s a part of this organization.See details»
Bioeclosion SL | MWC Barcelona
BioEclosion SL has developed a patented IVD device that enhances the current state of rapid diagnostics. The test integrates a single-use cartridge –specific for each application– and a …See details»
Jofre Ferrer-Dalmau - Co-Founder and CEO @ BioEclosion
Jofre Ferrer-Dalmau is the co-founder and CEO of BioEclosion.See details»
News – BioEclosion
BioEclosion S.L. has a key role in the consortium, as presented by CEO Dr. Jofre Ferrer-Dalmau in the meeting. The development and validation of BioEclosion’s MagnetPlex point-of-care …See details»
BioEclosion - Contacts, Employees, Board Members, Advisors
BioEclosion aims to contribute in the development of the next generation of rapid diagnostic test (RDTs) to solve societal challenges.See details»
Category: Projects - BioEclosion
BioEclosion S.L. has a key role in the consortium, as presented by CEO Dr. Jofre Ferrer-Dalmau in the meeting. The development and validation of BioEclosion’s MagnetPlex point-of-care …See details»
Patents - BioEclosion
PEPTIDE, MAGNETIC PEPTIDE AND METHOD FOR DETECTING CELIAC DISEASE The present invention relates to a method for detecting celiac disease using a peptide immobilized …See details»